Sanmario Pharmaceutical Private Limited
About Sanmario Pharmaceutical Private Limited
Data last updated:
Sanmario Pharmaceutical Private Limited is a private limited company based in Patna, Bihar, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 21 January 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U85300BR2015PTC023543.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Chandra Vijay Pratap and Rinky Singh.
Its last annual general meeting (AGM) was held on 30 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Patna, Bihar.
As per the financials filed for FY 2018, the company reported a revenue of ₹31.95 Lakh, a decline of 77% compared to the previous year. For the same year it recorded a net profit of ₹22,105 (net margin 0.7%) and EBITDA of ₹51,824 (EBITDA margin 1.6%). Revenue has grown at a compounded annual rate (CAGR) of 255% over three years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Sanmario Pharmaceutical Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressMansha Sree Kunj North West Nahar Kusumpuram Bailey Roa, D Danapur, Patna, Bihar, India – 801503
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Sanmario Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sanmario Pharmaceutical is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Sanmario Pharmaceutical Private Limited, buy the company report.
Financials of Sanmario Pharmaceutical Private Limited
FY 2018 filings availableSanmario Pharmaceutical Private Limited reported revenue of ₹31.95 Lakh (down 77% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue fell 77% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 255%. EBITDA fell 80% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹31.95 Lakh | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹51,824 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹22,105 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 | FY 2015-16 | FY 2014-15 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 0.7% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Sanmario Pharmaceutical Private Limited, buy the company report.
Board of directors of Sanmario Pharmaceutical Private Limited
Sanmario Pharmaceutical has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chandra Vijay Pratap | Director | 21 Jan 2015 | 11 Years 9 Months | Current |
| Rinky Singh | Director | 21 Jan 2015 | 11 Years 9 Months | Current |
Auditor
Sanmario Pharmaceutical Private Limited is audited by S B SHARMA & ASSOCIATES for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S B SHARMA & ASSOCIATES | FY 2018 | 016096C |
Shareholding
The shareholding of Sanmario Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sanmario Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Dec 2017 | 100157482 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Sanmario Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sanmario Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Sanmario Pharmaceutical Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Sanmario Pharmaceutical Private Limited has 2 board changes on record since 2015: 2 appointments. The latest: Chandra Vijay Pratap was appointed as Director on 21 Jan 2015.
Frequently asked questions
Sanmario Pharmaceutical is an active private limited company based in Patna, Bihar, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 21 January 2015 (11+ years old) and is registered under CIN U85300BR2015PTC023543.
Sanmario Pharmaceutical has 2 current directors:
- Chandra Vijay Pratap - Director
- Rinky Singh - Director
The latest financial statements of Sanmario Pharmaceutical on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 September 2018. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Sanmario Pharmaceutical is U85300BR2015PTC023543. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sanmario Pharmaceutical was incorporated on 21 January 2015, making it 11+ years old. It is registered with the Registrar of Companies, Patna.
Chandra Vijay Pratap was appointed as Director on 21 Jan 2015. Rinky Singh was appointed as Director on 21 Jan 2015.
The registered office of Sanmario Pharmaceutical is at Mansha Sree Kunj North West Nahar Kusumpuram Bailey Roa, D Danapur, Patna, Bihar, India – 801503.
Sanmario Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sanmario Pharmaceutical has open charges of ₹20 Lakh and no satisfied charges on record as per latest MCA filings.
The compliance status of Sanmario Pharmaceutical is compliant as of 21 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
